CD8A and neoplasm: On one hand, it can trigger the generation of anti-tumor cytotoxic effector cells, such as CD8+ T-cell antigen-specific lymphocytes and NK cells, on the other hand, it can stimulate the immunomodulatory function of Treg cells, leading to the inhibition and exhaustion of the anti-tumor immune response.